Biopharmaceuticals Market Research Report, Growth & Forecast

According to Stratistics MRC, the Global Biopharma Contract Services Market is accounted for $27.01 billion in 2025 and is expected to reach $51.97 billion by 2032 growing at a CAGR of 9.8% during the...

The global Biopharma Pump market size is predicted to grow from US$ 3970 million in 2025 to US$ 5199 million in 2032; it is expected to grow at a CAGR of 4.0% from 2026 to 2032. Biopharma Pump is a sp...

The global Chemistry, Manufacturing, and Controls (CMC) Service market size is predicted to grow from US$ 2201 million in 2025 to US$ 3309 million in 2032; it is expected to grow at a CAGR of 6.4% fro...

The global Lipid Nanoparticle (LNP) Analytical Services market size is predicted to grow from US$ 211 million in 2025 to US$ 348 million in 2032; it is expected to grow at a CAGR of 7.4% from 2026 to...

The global Lipid Nanoparticle (LNP) CDMO Service market size is predicted to grow from US$ 726 million in 2025 to US$ 1130 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032....

The global Microgravity Biomanufacturing market size is predicted to grow from US$ 77.46 million in 2025 to US$ 154 million in 2032; it is expected to grow at a CAGR of 10.5% from 2026 to 2032. Microg...

The global Microgravity Biopharmaceuticals market size is predicted to grow from US$ 63.97 million in 2025 to US$ 129 million in 2032; it is expected to grow at a CAGR of 10.6% from 2026 to 2032. Micr...

The global Outsource Drug Commercialization Service market size is predicted to grow from US$ 34619 million in 2025 to US$ 84459 million in 2032; it is expected to grow at a CAGR of 13.8% from 2026 to...

The global Outsourced Pharma Commercialization Service market size is predicted to grow from US$ 34619 million in 2025 to US$ 84459 million in 2032; it is expected to grow at a CAGR of 13.8% from 2026...

The global Antibody Drug CDMO Service market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Antibody Drug CDMO Servi...

The global Specialty Chemicals CDMO Service market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Specialty Chemical...

The global ADC Drug CDMO Service market size is predicted to grow from US$ 3316 million in 2025 to US$ 11430 million in 2032; it is expected to grow at a CAGR of 19.7% from 2026 to 2032. ADC drugs, al...

The Global Biopharmaceutical Fermentation Market is projected to expand from USD 25.11 Billion in 2025 to USD 40.99 Billion by 2031, reflecting a CAGR of 8.51%. This sector utilizes biological systems...

The Global Biopharmaceutical Fermentation System Market is projected to expand from USD 27.68 Billion in 2025 to USD 45.59 Billion by 2031, achieving a CAGR of 8.67%. These systems consist of speciali...

The Global mRNA Therapeutics Contract Development and Manufacturing (CDMO) Market is projected to increase from USD 9.99 billion in 2025 to USD 15.83 billion by 2031, expanding at a CAGR of 7.97%. Thi...

The Global Continuous Bioprocessing Market is projected to expand from USD 264.87 Million in 2025 to USD 464.39 Million by 2031, registering a CAGR of 9.81%. This sector revolves around a manufacturin...

The Global mRNA Platform Market is projected to expand from USD 7.52 Billion in 2025 to USD 9.59 Billion by 2031, reflecting a compound annual growth rate of 4.14%. This sector encompasses technologie...

The global biopharmaceutical excipients market size was estimated at USD 3.18 billion in 2025 and is projected to reach USD 4.97 billion by 2033, growing at a CAGR of 5.79% from 2026 to 2033. The indu...

This study covers the world outlook for Monoclonal Antibody (MAb)-based products across more than 190 countries. For each year ... demand, or the P.I.E., for Monoclonal Antibody (MAb)-based products. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also ...

This study covers the world outlook for protein drugs across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for protein drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country ...

This study covers the world outlook for monoclonal antibodies across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for monoclonal antibodies. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

... study covers the world outlook for next-generation antibodies across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for next-generation antibodies. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

... study covers the world outlook for next-generation biologics across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for next-generation biologics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

This study covers the world outlook for peptide therapeutics across more than ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for peptide therapeutics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

This study covers the world outlook for protein therapeutics across more than ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for protein therapeutics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

This study covers the world outlook for next generation antibody therapeutics across more than 190 countries. For each year ... demand, or the P.I.E., for next generation antibody therapeutics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also ...

... US$ in 2024, from 71000 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Biopharmaceutical Logistic in global market, especially in North America, Europe ...

According to our (Global Info Research) latest study, the global Biopharmaceuticals market size was valued at US$ 41640 million in 2025 and is forecast to a readjusted size of US$ 70090 million by 203...

This study covers the world outlook for advanced therapy medicinal products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ear...

This study covers the world outlook for albumin plasma protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ear...

This study covers the world outlook for monoclonal antibodies for inflammatory diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential...

This study covers the world outlook for monoclonal antibodies (mAbs) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...

This study covers the world outlook for monoclonal antibodies protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indus...

This study covers the world outlook for monoclonal antibody biopharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry...

This study covers the world outlook for opportunity assessment of RNA-based therapeutics and vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand,...

This study covers the world outlook for PEGylated protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings...

This study covers the world outlook for PEGylated proteins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...

This study covers the world outlook for plasma protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...

This study covers the world outlook for purified human proteins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...

This study covers the world outlook for upstream biopharmaceutical fermentation products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential...

The global Biopharmaceuticals market size is expected to reach $ 70090 million by 2032, rising at a market growth of 7.8% CAGR during the forecast period (2026-2032). A biopharmaceutical, also known a...

The global Biopharmaceutical Logistic market size is expected to reach $ 127620 million by 2032, rising at a market growth of 3.8% CAGR during the forecast period (2026-2032). Biopharmaceutical Logist...

The global mRNA synthesis raw materials market size was estimated at USD 1.73 billion in 2025 and is projected to reach USD 2.93 billion by 2033, growing at a CAGR of 7.10% from 2026 to 2033. The gro...

The global biopharmaceutical market size was estimated at USD 484.38 million in 2025 and is projected to reach USD 816.30 million by 2033, growing at a CAGR of 6.55% from 2026 to 2033. The biopharmac...

According to our latest research, the global BioPharma Service market size will reach USD million in 2031, growing at a CAGR of %over the analysis period. The global pharmaceutical market is 1475 bill...

According to our new research study on “Bulk Lyophilization Services Market Forecast to 2031 –Global Analysis – by Type, Material, and End User,” the market is anticipated to grow from US$ 839.19 mill...

The global oligonucleotide CDMO market size was estimated at USD 911.78 million in 2024 and is projected to reach USD 3,168.97 million by 2033, growing at a CAGR of 14.98% from 2025 to 2033. The mark...

The Middle East biopharmaceutical contract research organization market size was estimated at USD 875.4 million in 2024 and is projected to reach USD 1,736.5 million by 2033, growing at a CAGR of 8.0...

The Global Biopharmaceutical Market , valued at USD 435.82 Billion in 2024, is projected to experience a CAGR of 8.76% to reach USD 721.31 Billion by 2030. Biopharmaceuticals are therapeutic agents de...

The US bulk lyophilization services market size is expected to grow from US$ 340.37 million in 2024 and is projected to reach US$ 573.30 million by 2031; it is expected to register a CAGR of 7.8% duri...